Medication info
Telmisartan Tablet 80 mg (Telmisartan)

Telmisartan Tablet 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
White oval tablet
Packaging
30 tablets/box [(10 tablets/Alu-Alu x 3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201908249 · Approved 2019.12.05 · Insurance code 663608520

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients intolerant to ACE inhibitors
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine provides an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients intolerant to ACE inhibitors

  • Essential hypertension
View approved original text

This medication effectively lowers blood pressure in patients with essential hypertension, reducing the burden on the heart and blood vessels. It also helps reduce the risk of major cardiovascular diseases. It is particularly used in high-risk patients aged 55 and older who cannot use ACE inhibitors to lower the risk of myocardial infarction, stroke, and death from cardiovascular diseases. It plays a crucial role in protecting cardiovascular health and preventing complications. Therefore, this medication is effective for both blood pressure control and the prevention of cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine provides an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can pose a serious risk to the fetus during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication, and it is advisable to avoid it during breastfeeding. It is safe to avoid using this medication in patients with severe liver impairment, biliary obstruction, or cholestasis. Patients with a history of hereditary angioedema or who experienced angioedema while using ACE inhibitors or angiotensin II receptor antagonists should also avoid this medication. Diabetic patients or those with moderate to severe renal impairment should not combine this medication with certain drugs and should be cautious if renal function is diminished. Older adults, patients with hyperkalemia, patients with mild liver impairment, and patients with valvular heart disease or ischemic heart disease should use this medication with caution. If blood pressure drops excessively, serious problems such as myocardial infarction or stroke can occur, so caution is necessary. Although this medication lowers blood pressure, a variety of adverse reactions such as abdominal pain, diarrhea, headache, dizziness, cough, skin rash, etc., may occur. In particular, serious side effects such as angioedema, hyperkalemia, worsening renal function, liver dysfunction, interstitial pneumonia, and rhabdomyolysis can occur, so if any unusual symptoms appear, immediate medical attention should be sought. This medication can enhance the blood pressure-lowering effects when taken with other antihypertensive drugs, and there may be an increased risk of renal function deterioration or hyperkalemia when combined with certain drugs. Therefore, if you are taking other medications, be sure to inform your doctor or pharmacist, and regularly check renal function and electrolyte status through blood tests. Patients with low blood volume or sodium, and those undergoing surgery, should stabilize their condition before taking this medication, and if symptoms of hypotension appear, seek appropriate treatment immediately. This medication contains sorbitol, so it is not suitable for patients with fructose intolerance. Caution should be exercised when driving or operating machinery due to the risk of dizziness or fainting. In case of overdose, symptoms such as hypotension, dizziness, and acute kidney failure may occur, so immediate medical treatment is necessary. The safety and efficacy of this medication in children have not been established, so it is advisable not to use it in this population. When storing, keep this medication out of reach of children and be cautious of humidity; open the packaging just before use.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 107 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • vertigo
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • liver function abnormality
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • fatigue
  • hunger
  • cold sweat
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • fever
  • pneumonia
  • myalgia
  • elevated creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • lack of effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbance
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. Additionally, it is recommended to store the medication at room temperature between 1 degree and 30 degrees, avoiding extremely hot or cold environments.

Appearance and packaging

Appearance

White oval tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.